Cochrane Abstracts
Heparin versus placebo for non‐ST elevation acute coronary syndromes
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Heparin Versus Placebo for non‐ST Elevation Acute Coronary Syndromes." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439413/all/Heparin_versus_placebo_for_non‐ST_elevation_acute_coronary_syndromes.
Heparin versus placebo for non‐ST elevation acute coronary syndromes. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439413/all/Heparin_versus_placebo_for_non‐ST_elevation_acute_coronary_syndromes. Accessed March 24, 2025.
Heparin versus placebo for non‐ST elevation acute coronary syndromes. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439413/all/Heparin_versus_placebo_for_non‐ST_elevation_acute_coronary_syndromes
Heparin Versus Placebo for non‐ST Elevation Acute Coronary Syndromes [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439413/all/Heparin_versus_placebo_for_non‐ST_elevation_acute_coronary_syndromes.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Heparin versus placebo for non‐ST elevation acute coronary syndromes
ID - 439413
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439413/all/Heparin_versus_placebo_for_non‐ST_elevation_acute_coronary_syndromes
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
